Docetaxel with or without zoledronic acid for castration-resistant prostate cancer

Title
Docetaxel with or without zoledronic acid for castration-resistant prostate cancer
Authors
Keywords
Docetaxel, Zoledronic acid, Castration-resistant prostate cancer, Safety and efficacy
Journal
INTERNATIONAL UROLOGY AND NEPHROLOGY
Volume 46, Issue 12, Pages 2319-2326
Publisher
Springer Nature
Online
2014-09-15
DOI
10.1007/s11255-014-0824-9

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now